Neurotech Liabilities And Stockholders Equity from 2010 to 2024
| NTI Stock | 0.07 0 4.55% |
Liabilities And Stockholders Equity | First Reported 2010-12-31 | Previous Quarter 12.2 M | Current Value 12.8 M | Quarterly Volatility 3.8 M |
Check Neurotech International financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neurotech International's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 694.9 K or Total Revenue of 215.2 K, as well as many indicators such as . Neurotech financial statements analysis is a perfect complement when working with Neurotech International Valuation or Volatility modules.
Neurotech | Liabilities And Stockholders Equity |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Neurotech Stock Analysis
When running Neurotech International's price analysis, check to measure Neurotech International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurotech International is operating at the current time. Most of Neurotech International's value examination focuses on studying past and present price action to predict the probability of Neurotech International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurotech International's price. Additionally, you may evaluate how the addition of Neurotech International to your portfolios can decrease your overall portfolio volatility.